We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiotherapy Quality Assurance System Analyzes Dose in Isocentric Target Region

By HospiMedica International staff writers
Posted on 24 Nov 2009
In selecting a new quality assurance (QA) system for radiotherapy technology, cancer care physicists and physicians now have access to cutting-edge verification of radiation therapy treatment. More...
Key to this is the capability to perform real dose measurements and analyze the dose in the isocentric target region, the volume of greatest concern.

Advocate Lutheran General Hospital, in the Chicago suburb of Park Ridge, IL, USA, has chosen ScandiDos (Uppsala, Sweden) as the provider of its QA solution for its RapidArc radiotherapy system, developed by Varian Medical Systems. (Palo Alto, CA, USA), and in doing so, becomes the 100th clinical installation of Delta4. The Delta4 system is in clinical use for intensity-modulated radiation therapy (IMRT), arc therapy, and TomoTherapy since 2006 at clinics worldwide.

As Advocate Lutheran General Hospital begins treating patients with RapidArc--one form of volumetric modulated arc therapy (VMAT) or intensity-modulated arc therapy (IMAT), having Delta4 for the pretreatment measurement and analysis of treatment plans will provide clinicians the comfort and confidence to proceed with these new, advanced treatments. Delta4's unique approach to measuring and presenting the dose data in three dimensions allows for quick, easy, and precise analysis of the treatment in relation to the prescription dose to the patient.

The advanced analysis software allows the medical physicist to quickly analyze the measured dose against the treatment plan to determine the significance and cause of deviations in the dose. Because VMAT/IMAT modalities such as RapidArc by Varian Medical Systems employ many more treatment angles than conventional IMRT, an integral part of the analysis of such is the delivery of dose from each of the actual gantry angles that will be delivered to the patient and the independent verification of each gantry angle as an element of the dose analysis. Delta4 is the only volumetric QA system on the market to perform this independent gantry angle verification, and, as such, accounts for this area of potential discrepancy as part of its measurement.

"We are very pleased that Advocate Lutheran General Hospital has chosen Delta4 PT as part of the technology solution to offer advanced radiation treatments to its patients,” stated Brad Dugai, national sales manager at ScandiDos.

"When we installed our first Delta4 in 2006, it was used to verify both IMRT and Arc Therapy treatments. Now, 3 years later, rotational therapy is becoming the new standard radiation therapy and, significantly, our 100th installed system will be used for both TomoTherapy and Varian RapidArc,” said Ingemar Wiberg, VP of sales and marketing at ScandiDos.

Delta4 has been used by linear accelerator manufacturers in the development and validation of arc therapy treatment modalities to include Varian's RapidArc and Elekta's (Stockhom, Sweden) VMAT system.

ScandiDos introduced the new QA standard in advanced radiotherapy by moving into the era of three-dimensional (3D) and 4D volumetric dosimetry. ScandiDos goal is to provide complete dosimetry solutions that enable clinics around the world to implement new treatment modalities satisfying the demand on accuracy in dose verification and patient throughput.

Related Links:
ScandiDos
Varian Medical Systems



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.